TTTS I期与II期及III期与IV期之间的区分不影响激光治疗后的双胎存活概率
单中心研究纳入1020例接受胎儿镜激光手术的重度TTTS连续病例,按Quintero分期分析围产期结局。双胎存活率在I期69.0%、II期71.4%、III期55.4%、IV期51.0%,I期与II期之间及III期与IV期之间存活率无显著差异;合并I+II期双胎存活率70.6% vs 合并III+IV期54.9%(P<0.001)。
要点
- TTTS双胎存活与Quintero分期显著相关,III+IV期双胎存活率低于I+II期。
- I期与II期之间、III期与IV期之间双胎存活率无显著差异。
- III期供血儿多普勒严重异常者双胎存活率最低,为45.4%(64/141)。
诊断标准与关键数值
- 双胎存活率:I期69.0%(127/184)、II期71.4%(257/360)、III期55.4%(236/426)、IV期51.0%(25/49)。
- 至少一胎存活率:I期91.3%(168/184)、II期89.7%(323/360)、III期83.1%(354/426)、IV期77.6%(38/49)。
- II期 vs III期双胎存活率P<0.001、至少一胎存活率P=0.011,均为II期显著高于III期;I期 vs II期及III期 vs IV期存活率无显著差异。
- 合并I+II期双胎存活率70.6%(384/544) vs 合并III+IV期54.9%(261/475),P<0.001;至少一胎存活率90.3%(491/544) vs 82.5%(392/475),P<0.001。
- III期供血儿多普勒严重异常者双胎存活率最低,为45.4%(64/141)。
临床应用与阅片要点
- 报告TTTS病例时可按Quintero分期记录,但I期与II期之间、III期与IV期之间的区分对激光术后双胎存活的预后判断无显著附加价值。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To compare the perinatal outcome of monochorionic twin pregnancies with twin-twin transfusion syndrome (TTTS), according to the disease severity, defined using Quintero staging, after treatment with fetoscopic laser surgery.
METHODS: This was a single-center study of 1020 consecutive cases with severe TTTS, which were treated with fetoscopic laser surgery. During the study period from January 1995 to March 2013, the participants were included at a mean ± SD gestational age of 20.8 ± 2.2 weeks. Perinatal survival analysis, including the rates of double survival and survival of at least one fetus, was undertaken according to the Quintero staging system. For blockwise comparisons of data, the whole population was divided into five chronologically consecutive study subgroups of 200 patients in each of the first four subgroups and 220 in the last one.
RESULTS: For the entire study population with known outcome (n = 1019), the rate of pregnancy with double fetal survival was 69.0% (127/184) in Stage-I, 71.4% (257/360) in Stage-II, 55.4% (236/426) in Stage-III and 51.0% (25/49) in Stage-IV TTTS cases. At least one twin survived in 91.3% (168/184) of pregnancies with Stage-I, 89.7% (323/360) of those with Stage-II, 83.1% (354/426) of those with Stage-III and 77.6% (38/49) of those with Stage-IV TTTS. The rates of double survival and survival of at least one fetus were both significantly higher in Stage-II TTTS compared with those in Stage-III TTTS cases (P < 0.001 and P = 0.011, respectively). Survival rates between pregnancies with Stage-I vs Stage-II TTTS and between those with Stage-III vs Stage-IV TTTS were not significantly different. Therefore, we combined pregnancies with Stage-I or Stage-II TTTS, and those with Stage-III or Stage-IV TTTS. The double survival rate was 70.6% (384/544) in combined Stage-I and Stage-II vs 54.9% (261/475) in combined Stage-III and Stage-IV TTTS cases (P < 0.001). At least one twin survived in 90.3% (491/544) of pregnancies with Stage-I or Stage-II TTTS vs 82.5% (392/475) in those with Stage-III or Stage-IV TTTS (P < 0.001). The double survival rate increased between the first and the last consecutive study subgroups from 59.8% (55/92) to 75.0% (96/128) (adjusted odds ratio (aOR)linear trend , 1.26 (95% CI, 1.01-1.56); P = 0.037) in pregnancies with Stage-I or Stage-II TTTS and from 41.7% (45/108) to 62.0% (57/92) (aORlinear trend , 1.21 (95% CI, 0.98-1.50); P = 0.082) in those with Stage-III or Stage-IV TTTS. Double survival rate was the lowest for Stage-III cases in which the donor twin was affected by severely abnormal Doppler findings (45.4% (64/141)).
CONCLUSIONS: Double survival and survival of at least one fetus in monochorionic twin pregnancies with TTTS were related significantly to Quintero stage. However, our data show that the differentiation between Stages I vs II and Stages III vs IV does not have any significant prognostic implication for perinatal survival. © 2020 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Bamberg C, Diehl W, Diemert A, et al. Differentiation between TTTS Stages I vs II and III vs IV does not affect probability of double survival after laser therapy. Ultrasound Obstet Gynecol. 2021. PMID: 32959919. doi:10.1002/uog.23131
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。